Language selection

Search

2005-02-23 - Female

181570

Adverse reaction report number 181570
Latest AER version number 0
Market authorization holder AER number SUS12005000095
Initial received date 2005-02-23
Latest received date 2005-02-23
Age N/A
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization Yes
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Hallucination
Date modified: